According to Latest Research Study, the global market for Prescription Weight Loss Pills should grow from US$ 1130 million in 2022 to US$ 2625.3 million by 2029, with a CAGR of 10.4% for the period of 2023-2029.

China Prescription Weight Loss Pills market should grow from US$ million in 2024 to US$ million by 2030, with a CAGR of % for the period of 2024-2030.

The United States Prescription Weight Loss Pills market should grow from US$ million in 2024 to US$ million by 2030, with a CAGR of % for the period of 2024-2030.

In terms of type, Oral Tablets segment holds a share about % in 2022 and will reach % in 2029; while in terms of application, Hospital has a share approximately % in 2022 and will grow at a CAGR % during 2023 and 2029.

The global key manufacturers of Prescription Weight Loss Pills include Currax Pharmaceuticals (Contrave), VIVUS (Qsymia), Novo Nordisk A/S, Rhythm Pharmaceuticals (Imcivree), Eli Lilly and Company (TRICARE), CHEPLAPHARM (Xenical), Pfizer, Teva Pharmaceutical (Actavis) and Haleon Group (alli), etc. In 2022, the global top five players hold a share approximately % in terms of revenue.

Health care professionals use the Body Mass Index (BMI), a measure of people weight in relation to height, to define overweight and obesity. People who have a BMI between 25 and 30 are considered to be overweight. Obesity is defined as having a BMI of 30 or greater. Are overweight, obese, or severely obese, which may increase risk of developing health problems. Obesity is a chronic disease and prescription medications to treat overweight and obesity work in different ways. Prescription weight loss medicines can help obese people lose weight. They are usually prescribed by a doctor when diet and exercise alone are not working. Each of these medicines works differently. People who use these medicines may not feel as hungry. Or they may feel full after eating only a small amount of food. Another type of weight-loss medicine makes it harder for your body to absorb fat. Prescription weight loss drugs can be helpful when used in combination with a low-calorie diet and regular physical activity.

This report aims to provide a comprehensive study of the global market for Prescription Weight Loss Pills.
Report Highlights:

(1) Global Prescription Weight Loss Pills market size (sales volume & revenue), history data from 2019-2023 and forecast data from 2024 to 2030.

(2) Global Prescription Weight Loss Pills market competitive situation, sales, revenue, price and market share, from 2019 to 2024.

(3) China Prescription Weight Loss Pills market competitive situation, sales, revenue, price and market share, from 2019 to 2024.

(4) Global Prescription Weight Loss Pills segment by region (or country), key regions cover the United States, Europe, Japan, South Korea, Southeast Asia and India, etc.

(5) Global Prescription Weight Loss Pills segment by type and by application and regional segment by type and by application.

(6) Global major production regions of Prescription Weight Loss Pills, capacity, production and trends.

(7) Prescription Weight Loss Pills industry supply chain, upstream, midstream and downstream analysis.

Market segment by regions, regional analysis covers

North America (United States, Canada and Mexico)

Europe (Germany, France, UK, Russia, Italy and Rest of Europe)

Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia and Rest of Asia-Pacific)

South America (Brazil, Rest of South America)

Middle East & Africa

Market segment by type, covers

Oral Tablets

Oral Capsules

Injections

Market segment by application, can be divided into

Hospital

Pharmacy

Market segment by players, this report covers

Currax Pharmaceuticals (Contrave)

VIVUS (Qsymia)

Novo Nordisk A/S

Rhythm Pharmaceuticals (Imcivree)

Eli Lilly and Company (TRICARE)

CHEPLAPHARM (Xenical)

Pfizer

Teva Pharmaceutical (Actavis)

Haleon Group (alli)

Sanofi (Adlyxin)

AstraZeneca (BYDUREON BCise)

1 Market Overview

1.1 Prescription Weight Loss Pills Definition

1.2 Global Prescription Weight Loss Pills Market Size and Forecast

1.2.1 By Revenue, Global Prescription Weight Loss Pills Market Size, 2019-2030

1.2.2 By Sales Volume, Global Prescription Weight Loss Pills Market Size, 2019-2030

1.2.3 Global Prescription Weight Loss Pills Price Trend, 2019-2030

1.3 China Prescription Weight Loss Pills Market Size and Forecast

1.3.1 By Revenue, China Prescription Weight Loss Pills Market Size, 2019-2030

1.3.2 By Sales Volume, China Prescription Weight Loss Pills Market Size, 2019-2030

1.3.3 China Prescription Weight Loss Pills Price Trend, 2019-2030

1.4 China Percentage in Global Market

1.4.1 By Revenue, China Prescription Weight Loss Pills Share in Global Market, 2019-2030

1.4.2 By Sales Volume, China Prescription Weight Loss Pills Share in Global Market, 2019-2030

1.4.3 Prescription Weight Loss Pills Market Size: China VS Global, 2019-2030

1.5 Prescription Weight Loss Pills Market Dynamics

1.5.1 Prescription Weight Loss Pills Market Drivers

1.5.2 Prescription Weight Loss Pills Market Restraints

1.5.3 Prescription Weight Loss Pills Industry Trends

1.5.4 Prescription Weight Loss Pills Industry Policy

2 Global Competitive Landscape by Company

2.1 Global Prescription Weight Loss Pills Revenue by Company, 2019-2024

2.2 Global Prescription Weight Loss Pills Sales Volume by Company, 2019-2024

2.3 Global Prescription Weight Loss Pills Price by Company, 2019-2024

2.4 Global Prescription Weight Loss Pills Participants, Market Position (Tier 1, Tier 2 and Tier 3)

2.5 Global Prescription Weight Loss Pills Concentration Ratio

2.6 Global Prescription Weight Loss Pills Mergers & Acquisitions, Expansion Plans

2.7 Global Prescription Weight Loss Pills Manufacturers Product Type

3 China Competitive Landscape by Company

3.1 China Prescription Weight Loss Pills Revenue by Company, 2019-2024

3.2 China Prescription Weight Loss Pills Sales Volume by Company, 2019-2024

3.3 China Prescription Weight Loss Pills Prescription Weight Loss Pills Participants, Market Position (Tier 1, Tier 2 and Tier 3)

3.4 China Prescription Weight Loss Pills Market, Sales Percentage of Local Players VS Foreign Players (2019-2024)

3.5 Chinese Local Players, Prescription Weight Loss Pills Domestic VS Export

3.6 China Market, Prescription Weight Loss Pills Import & Export

3.6.1 China Market, Prescription Weight Loss Pills Import & Export, 2019-2030

3.6.2 China Prescription Weight Loss Pills Import & Export Trends

3.6.3 Main Sources of China Prescription Weight Loss Pills Import

3.6.4 Export Destination of China Prescription Weight Loss Pills

4 Prescription Weight Loss Pills Production by Region

4.1 Global Prescription Weight Loss Pills Capacity, Production and Capacity Utilization, 2019-2030

4.2 Global Geographic Distribution of Prescription Weight Loss Pills Manufacturers

4.3 Global Major Manufacturers, Prescription Weight Loss Pills Capacity Expansion and Future Plans

4.4 Global Prescription Weight Loss Pills Capacity by Region

4.5 Global Prescription Weight Loss Pills Production by Region

4.5.1 Global Prescription Weight Loss Pills Production & Forecast by Region, 2019 VS 2024 VS 2030

4.5.2 Global Prescription Weight Loss Pills Production by Region, 2019-2024

4.5.3 Global Prescription Weight Loss Pills Production Market Share & Forecast by Region, 2019-2030

5 Industry Chain Analysis

5.1 Prescription Weight Loss Pills Industry Chain

5.2 Prescription Weight Loss Pills Upstream Analysis

5.2.1 Prescription Weight Loss Pills Core Raw Materials

5.2.2 Main Manufacturers of Prescription Weight Loss Pills Core Raw Materials

5.3 Midstream Analysis

5.4 Downstream Analysis

5.5 Prescription Weight Loss Pills Production Mode

5.6 Prescription Weight Loss Pills Procurement Model

5.7 Prescription Weight Loss Pills Industry Sales Model and Sales Channels

5.7.1 Prescription Weight Loss Pills Sales Model

5.7.2 Prescription Weight Loss Pills Typical Distributors

6 Sights by Type

6.1 Prescription Weight Loss Pills Classification

6.1.1 Oral Tablets

6.1.2 Oral Capsules

6.1.3 Injections

6.2 By Type, Global Prescription Weight Loss Pills Market Size & CAGR, 2019 VS 2024 VS 2030

6.3 By Type, Global Prescription Weight Loss Pills Revenue, 2019-2030

6.4 By Type, Global Prescription Weight Loss Pills Sales Volume, 2019-2030

6.5 By Type, Global Prescription Weight Loss Pills Price, 2019-2030

7 Sights by Application

7.1 Prescription Weight Loss Pills Segment by Application

7.1.1 Hospital

7.1.2 Pharmacy

7.2 By Application, Global Prescription Weight Loss Pills Market Size & CAGR, 2019 VS 2024 VS 2030

7.3 By Application, Global Prescription Weight Loss Pills Revenue, 2019-2030

7.4 By Application, Global Prescription Weight Loss Pills Sales Volume, 2019-2030

7.5 By Application, Global Prescription Weight Loss Pills Price, 2019-2030

8 Sales Sights by Region

8.1 By Region, Global Prescription Weight Loss Pills Market Size, 2019 VS 2024 VS 2030

8.2 By Region, Global Prescription Weight Loss Pills Revenue, 2019-2030

8.3 By Region, Global Prescription Weight Loss Pills Sales Volume, 2019-2030

8.4 North America

8.4.1 North America Prescription Weight Loss Pills Market Size & Forecasts, 2019-2030

8.4.2 By Country, North America Prescription Weight Loss Pills Market Size Market Share

8.5 Europe

8.5.1 Europe Prescription Weight Loss Pills Market Size & Forecasts, 2019-2030

8.5.2 By Country, Europe Prescription Weight Loss Pills Market Size Market Share

8.6 Asia Pacific

8.6.1 Asia Pacific Prescription Weight Loss Pills Market Size & Forecasts, 2019-2030

8.6.2 By Country/Region, Asia Pacific Prescription Weight Loss Pills Market Size Market Share

8.7 South America

8.7.1 South America Prescription Weight Loss Pills Market Size & Forecasts, 2019-2030

8.7.2 By Country, South America Prescription Weight Loss Pills Market Size Market Share

8.8 Middle East & Africa

9 Sales Sights by Country Level

9.1 By Country, Global Prescription Weight Loss Pills Market Size & CAGR，2019 VS 2024 VS 2030

9.2 By Country, Global Prescription Weight Loss Pills Revenue, 2019-2030

9.3 By Country, Global Prescription Weight Loss Pills Sales Volume, 2019-2030

9.4 U.S.

9.4.1 U.S. Prescription Weight Loss Pills Market Size, 2019-2030

9.4.2 By Company, U.S. Prescription Weight Loss Pills Sales Volume Market Share, 2024

9.4.3 By Type, U.S. Prescription Weight Loss Pills Market Size, Share, 2024 VS 2030

9.4.4 By Application, U.S. Prescription Weight Loss Pills Market Size, Share, 2024 VS 2030

9.5 Europe

9.5.1 Europe Prescription Weight Loss Pills Market Size, 2019-2030

9.5.2 By Company, Europe Prescription Weight Loss Pills Sales Volume Market Share, 2024

9.5.3 By Type, Europe Prescription Weight Loss Pills Market Size, Share, 2024 VS 2030

9.5.4 By Application, Europe Prescription Weight Loss Pills Market Size, Share, 2024 VS 2030

9.6 China

9.6.1 China Prescription Weight Loss Pills Market Size, 2019-2030

9.6.2 By Company, China Prescription Weight Loss Pills Sales Volume Market Share, 2024

9.6.3 By Type, China Prescription Weight Loss Pills Market Size, Share, 2024 VS 2030

9.6.4 By Application, China Prescription Weight Loss Pills Market Size, Share, 2024 VS 2030

9.7 Japan

9.7.1 Japan Prescription Weight Loss Pills Market Size, 2019-2030

9.7.2 By Company, Japan Prescription Weight Loss Pills Sales Volume Market Share, 2024

9.7.3 By Type, Japan Prescription Weight Loss Pills Market Size, Share, 2024 VS 2030

9.7.4 By Application, Japan Prescription Weight Loss Pills Market Size, Share, 2024 VS 2030

9.8 South Korea

9.8.1 South Korea Prescription Weight Loss Pills Market Size, 2019-2030

9.8.2 By Company, South Korea Prescription Weight Loss Pills Sales Volume Market Share, 2024

9.8.3 By Type, South Korea Prescription Weight Loss Pills Market Size, Share, 2024 VS 2030

9.8.4 By Application, South Korea Prescription Weight Loss Pills Market Size, Share, 2024 VS 2030

9.9 Southeast Asia

9.9.1 Southeast Asia Prescription Weight Loss Pills Market Size, 2019-2030

9.9.2 By Company, Southeast Asia Prescription Weight Loss Pills Sales Volume Market Share, 2024

9.9.3 By Type, Southeast Asia Prescription Weight Loss Pills Market Size, Share, 2024 VS 2030

9.9.4 By Application, Southeast Asia Prescription Weight Loss Pills Market Size, Share, 2024 VS 2030

9.10 India

9.10.1 India Prescription Weight Loss Pills Market Size, 2019-2030

9.10.2 By Company, India Prescription Weight Loss Pills Sales Volume Market Share, 2024

9.10.3 By Type, India Prescription Weight Loss Pills Market Size, Share, 2024 VS 2030

9.10.4 By Application, India Prescription Weight Loss Pills Market Size, Share, 2024 VS 2030

9.11 Middle East & Asia

9.11.1 Middle East & Asia Prescription Weight Loss Pills Market Size, 2019-2030

9.11.2 By Company, Middle East & Asia Prescription Weight Loss Pills Sales Volume Market Share, 2024

9.11.3 By Type, Middle East & Asia Prescription Weight Loss Pills Market Size, Share, 2024 VS 2030

9.11.4 By Application, Middle East & Asia Prescription Weight Loss Pills Market Size, Share, 2024 VS 2030

10 Manufacturers Profile

10.1 Currax Pharmaceuticals (Contrave)

10.1.1 Currax Pharmaceuticals (Contrave) Company Information, Head Office, Market Area and Industry Position

10.1.2 Currax Pharmaceuticals (Contrave) Prescription Weight Loss Pills Models, Specifications and Application

10.1.3 Currax Pharmaceuticals (Contrave) Prescription Weight Loss Pills Sales Volume, Revenue, Price and Gross Margin, 2019-2024

10.1.4 Currax Pharmaceuticals (Contrave) Company Profile and Main Business

10.1.5 Currax Pharmaceuticals (Contrave) Recent Developments

10.2 VIVUS (Qsymia)

10.2.1 VIVUS (Qsymia) Company Information, Head Office, Market Area and Industry Position

10.2.2 VIVUS (Qsymia) Prescription Weight Loss Pills Models, Specifications and Application

10.2.3 VIVUS (Qsymia) Prescription Weight Loss Pills Sales Volume, Revenue, Price and Gross Margin, 2019-2024

10.2.4 VIVUS (Qsymia) Company Profile and Main Business

10.2.5 VIVUS (Qsymia) Recent Developments

10.3 Novo Nordisk A/S

10.3.1 Novo Nordisk A/S Company Information, Head Office, Market Area and Industry Position

10.3.2 Novo Nordisk A/S Prescription Weight Loss Pills Models, Specifications and Application

10.3.3 Novo Nordisk A/S Prescription Weight Loss Pills Sales Volume, Revenue, Price and Gross Margin, 2019-2024

10.3.4 Novo Nordisk A/S Company Profile and Main Business

10.3.5 Novo Nordisk A/S Recent Developments

10.4 Rhythm Pharmaceuticals (Imcivree)

10.4.1 Rhythm Pharmaceuticals (Imcivree) Company Information, Head Office, Market Area and Industry Position

10.4.2 Rhythm Pharmaceuticals (Imcivree) Prescription Weight Loss Pills Models, Specifications and Application

10.4.3 Rhythm Pharmaceuticals (Imcivree) Prescription Weight Loss Pills Sales Volume, Revenue, Price and Gross Margin, 2019-2024

10.4.4 Rhythm Pharmaceuticals (Imcivree) Company Profile and Main Business

10.4.5 Rhythm Pharmaceuticals (Imcivree) Recent Developments

10.5 Eli Lilly and Company (TRICARE)

10.5.1 Eli Lilly and Company (TRICARE) Company Information, Head Office, Market Area and Industry Position

10.5.2 Eli Lilly and Company (TRICARE) Prescription Weight Loss Pills Models, Specifications and Application

10.5.3 Eli Lilly and Company (TRICARE) Prescription Weight Loss Pills Sales Volume, Revenue, Price and Gross Margin, 2019-2024

10.5.4 Eli Lilly and Company (TRICARE) Company Profile and Main Business

10.5.5 Eli Lilly and Company (TRICARE) Recent Developments

10.6 CHEPLAPHARM (Xenical)

10.6.1 CHEPLAPHARM (Xenical) Company Information, Head Office, Market Area and Industry Position

10.6.2 CHEPLAPHARM (Xenical) Prescription Weight Loss Pills Models, Specifications and Application

10.6.3 CHEPLAPHARM (Xenical) Prescription Weight Loss Pills Sales Volume, Revenue, Price and Gross Margin, 2019-2024

10.6.4 CHEPLAPHARM (Xenical) Company Profile and Main Business

10.6.5 CHEPLAPHARM (Xenical) Recent Developments

10.7 Pfizer

10.7.1 Pfizer Company Information, Head Office, Market Area and Industry Position

10.7.2 Pfizer Prescription Weight Loss Pills Models, Specifications and Application

10.7.3 Pfizer Prescription Weight Loss Pills Sales Volume, Revenue, Price and Gross Margin, 2019-2024

10.7.4 Pfizer Company Profile and Main Business

10.7.5 Pfizer Recent Developments

10.8 Teva Pharmaceutical (Actavis)

10.8.1 Teva Pharmaceutical (Actavis) Company Information, Head Office, Market Area and Industry Position

10.8.2 Teva Pharmaceutical (Actavis) Prescription Weight Loss Pills Models, Specifications and Application

10.8.3 Teva Pharmaceutical (Actavis) Prescription Weight Loss Pills Sales Volume, Revenue, Price and Gross Margin, 2019-2024

10.8.4 Teva Pharmaceutical (Actavis) Company Profile and Main Business

10.8.5 Teva Pharmaceutical (Actavis) Recent Developments

10.9 Haleon Group (alli)

10.9.1 Haleon Group (alli) Company Information, Head Office, Market Area and Industry Position

10.9.2 Haleon Group (alli) Prescription Weight Loss Pills Models, Specifications and Application

10.9.3 Haleon Group (alli) Prescription Weight Loss Pills Sales Volume, Revenue, Price and Gross Margin, 2019-2024

10.9.4 Haleon Group (alli) Company Profile and Main Business

10.9.5 Haleon Group (alli) Recent Developments

10.10 Sanofi (Adlyxin)

10.10.1 Sanofi (Adlyxin) Company Information, Head Office, Market Area and Industry Position

10.10.2 Sanofi (Adlyxin) Prescription Weight Loss Pills Models, Specifications and Application

10.10.3 Sanofi (Adlyxin) Prescription Weight Loss Pills Sales Volume, Revenue, Price and Gross Margin, 2019-2024

10.10.4 Sanofi (Adlyxin) Company Profile and Main Business

10.10.5 Sanofi (Adlyxin) Recent Developments

10.11 AstraZeneca (BYDUREON BCise)

10.11.1 AstraZeneca (BYDUREON BCise) Company Information, Head Office, Market Area and Industry Position

10.11.2 AstraZeneca (BYDUREON BCise) Prescription Weight Loss Pills Models, Specifications and Application

10.11.3 AstraZeneca (BYDUREON BCise) Prescription Weight Loss Pills Sales Volume, Revenue, Price and Gross Margin, 2019-2024

10.11.4 AstraZeneca (BYDUREON BCise) Company Profile and Main Business

10.11.5 AstraZeneca (BYDUREON BCise) Recent Developments

11 Conclusion

12 Appendix

12.1 Research Methodology

12.2 Data Source

12.2.1 Secondary Sources

12.2.2 Primary Sources

12.3 Market Estimation Model

12.4 Disclaimer

Table 1. Prescription Weight Loss Pills Market Size & CAGR: China VS Global, 2019-2030, US$ Million

Table 2. Prescription Weight Loss Pills Market Restraints

Table 3. Prescription Weight Loss Pills Market Trends

Table 4. Prescription Weight Loss Pills Industry Policy

Table 5. Global Prescription Weight Loss Pills Revenue by Company, 2019-2024, US$ million

Table 6. Global Prescription Weight Loss Pills Revenue Market Share by Company, 2019-2024

Table 7. Global Prescription Weight Loss Pills Sales Volume by Company, 2019-2024, (K Units)

Table 8. Global Prescription Weight Loss Pills Sales Volume Market Share by Company, 2019-2024

Table 9. Global Prescription Weight Loss Pills Price by Company, 2019-2024, (US$/Unit)

Table 10. Global Prescription Weight Loss Pills Manufacturers Market Concentration Ratio (CR3 and HHI)

Table 11. Global Prescription Weight Loss Pills Mergers & Acquisitions, Expansion Plans

Table 12. Global Prescription Weight Loss Pills Manufacturers Product Type

Table 13. China Prescription Weight Loss Pills Revenue by Company, 2019-2024, US$ million

Table 14. China Prescription Weight Loss Pills Revenue Market Share by Company, 2019-2024

Table 15. China Prescription Weight Loss Pills Sales Volume by Company, 2019-2024, (K Units)

Table 16. China Prescription Weight Loss Pills Sales Volume Market Share by Company, 2019-2024

Table 17. China Market, Prescription Weight Loss Pills Production, Sales, Import and Export, 2019-2030, (K Units)

Table 18. China Prescription Weight Loss Pills Import & Export Trends

Table 19. Main Sources of China Prescription Weight Loss Pills Import

Table 20. Export Destination of China Prescription Weight Loss Pills

Table 21. Global Headquarters and Manufacturing Base of Prescription Weight Loss Pills Manufacturers

Table 22. Global Major Manufacturers, Prescription Weight Loss Pills Capacity Expansion and Future Plans

Table 23. Global Prescription Weight Loss Pills Production & Forecast by Region, 2019 VS 2024 VS 2030, (K Units)

Table 24. Global Prescription Weight Loss Pills Production by Region, 2019-2024, (K Units)

Table 25. Global Prescription Weight Loss Pills Production Forecast by Region, 2024-2030, (K Units)

Table 26. Global Key Players of Prescription Weight Loss Pills Upstream (Raw Materials)

Table 27. Global Prescription Weight Loss Pills Typical Customers

Table 28. Prescription Weight Loss Pills Typical Distributors

Table 29. By Type, Global Prescription Weight Loss Pills Revenue & CAGR, 2019 VS 2024 VS 2030, US$ Million

Table 30. By Application, Global Prescription Weight Loss Pills Revenue & CAGR, 2019 VS 2024 VS 2030, US$ Million

Table 31. By Region, Global Prescription Weight Loss Pills Market Size, 2019 VS 2024 VS 2030, US$ Million

Table 32. By Region, Global Prescription Weight Loss Pills Revenue, 2019-2030, US$ Million

Table 33. By Region, Global Prescription Weight Loss Pills Sales Volume, 2019-2030, (K Units)

Table 34. By Country, Global Prescription Weight Loss Pills Revenue & CAGR，2019 VS 2024 VS 2030, US$ Million

Table 35. By Country, Global Prescription Weight Loss Pills Revenue, 2019-2030, US$ Million

Table 36. By Country, Global Prescription Weight Loss Pills Revenue Market Share, 2019-2030

Table 37. By Country, Global Prescription Weight Loss Pills Sales Volume, 2019-2030, (K Units)

Table 38. By Country, Global Prescription Weight Loss Pills Sales Volume Market Share, 2019-2030

Table 39. Currax Pharmaceuticals (Contrave) Company Information, Head Office, Market Area and Industry Position

Table 40. Currax Pharmaceuticals (Contrave) Prescription Weight Loss Pills Models, Specifications and Application

Table 41. Currax Pharmaceuticals (Contrave) Prescription Weight Loss Pills Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2019-2024

Table 42. Currax Pharmaceuticals (Contrave) Company Profile and Main Business

Table 43. Currax Pharmaceuticals (Contrave) Recent Developments

Table 44. VIVUS (Qsymia) Company Information, Head Office, Market Area and Industry Position

Table 45. VIVUS (Qsymia) Prescription Weight Loss Pills Models, Specifications and Application

Table 46. VIVUS (Qsymia) Prescription Weight Loss Pills Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2019-2024

Table 47. VIVUS (Qsymia) Company Profile and Main Business

Table 48. VIVUS (Qsymia) Recent Developments

Table 49. Novo Nordisk A/S Company Information, Head Office, Market Area and Industry Position

Table 50. Novo Nordisk A/S Prescription Weight Loss Pills Models, Specifications and Application

Table 51. Novo Nordisk A/S Prescription Weight Loss Pills Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2019-2024

Table 52. Novo Nordisk A/S Company Profile and Main Business

Table 53. Novo Nordisk A/S Recent Developments

Table 54. Rhythm Pharmaceuticals (Imcivree) Company Information, Head Office, Market Area and Industry Position

Table 55. Rhythm Pharmaceuticals (Imcivree) Prescription Weight Loss Pills Models, Specifications and Application

Table 56. Rhythm Pharmaceuticals (Imcivree) Prescription Weight Loss Pills Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2019-2024

Table 57. Rhythm Pharmaceuticals (Imcivree) Company Profile and Main Business

Table 58. Rhythm Pharmaceuticals (Imcivree) Recent Developments

Table 59. Eli Lilly and Company (TRICARE) Company Information, Head Office, Market Area and Industry Position

Table 60. Eli Lilly and Company (TRICARE) Prescription Weight Loss Pills Models, Specifications and Application

Table 61. Eli Lilly and Company (TRICARE) Prescription Weight Loss Pills Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2019-2024

Table 62. Eli Lilly and Company (TRICARE) Company Profile and Main Business

Table 63. Eli Lilly and Company (TRICARE) Recent Developments

Table 64. CHEPLAPHARM (Xenical) Company Information, Head Office, Market Area and Industry Position

Table 65. CHEPLAPHARM (Xenical) Prescription Weight Loss Pills Models, Specifications and Application

Table 66. CHEPLAPHARM (Xenical) Prescription Weight Loss Pills Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2019-2024

Table 67. CHEPLAPHARM (Xenical) Company Profile and Main Business

Table 68. CHEPLAPHARM (Xenical) Recent Developments

Table 69. Pfizer Company Information, Head Office, Market Area and Industry Position

Table 70. Pfizer Prescription Weight Loss Pills Models, Specifications and Application

Table 71. Pfizer Prescription Weight Loss Pills Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2019-2024

Table 72. Pfizer Company Profile and Main Business

Table 73. Pfizer Recent Developments

Table 74. Teva Pharmaceutical (Actavis) Company Information, Head Office, Market Area and Industry Position

Table 75. Teva Pharmaceutical (Actavis) Prescription Weight Loss Pills Models, Specifications and Application

Table 76. Teva Pharmaceutical (Actavis) Prescription Weight Loss Pills Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2019-2024

Table 77. Teva Pharmaceutical (Actavis) Company Profile and Main Business

Table 78. Teva Pharmaceutical (Actavis) Recent Developments

Table 79. Haleon Group (alli) Company Information, Head Office, Market Area and Industry Position

Table 80. Haleon Group (alli) Prescription Weight Loss Pills Models, Specifications and Application

Table 81. Haleon Group (alli) Prescription Weight Loss Pills Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2019-2024

Table 82. Haleon Group (alli) Company Profile and Main Business

Table 83. Haleon Group (alli) Recent Developments

Table 84. Sanofi (Adlyxin) Company Information, Head Office, Market Area and Industry Position

Table 85. Sanofi (Adlyxin) Prescription Weight Loss Pills Models, Specifications and Application

Table 86. Sanofi (Adlyxin) Prescription Weight Loss Pills Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2019-2024

Table 87. Sanofi (Adlyxin) Company Profile and Main Business

Table 88. Sanofi (Adlyxin) Recent Developments

Table 89. AstraZeneca (BYDUREON BCise) Company Information, Head Office, Market Area and Industry Position

Table 90. AstraZeneca (BYDUREON BCise) Prescription Weight Loss Pills Models, Specifications and Application

Table 91. AstraZeneca (BYDUREON BCise) Prescription Weight Loss Pills Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2019-2024

Table 92. AstraZeneca (BYDUREON BCise) Company Profile and Main Business

Table 93. AstraZeneca (BYDUREON BCise) Recent Developments

List of Figure

Figure 1. Prescription Weight Loss Pills Picture

Figure 2. By Revenue, Global Prescription Weight Loss Pills Market Size and Forecast, 2019-2030, US$ Million

Figure 3. By Sales Volume, Global Prescription Weight Loss Pills Market Size and Forecast, 2019-2030, (K Units)

Figure 4. Global Prescription Weight Loss Pills Price Trend, 2019-2030, (US$/Unit)

Figure 5. By Revenue, China Prescription Weight Loss Pills Market Size and Forecast, 2019-2030, US$ million

Figure 6. By Sales Volume, China Prescription Weight Loss Pills Market Size and Forecast, 2019-2030, (K Units)

Figure 7. China Prescription Weight Loss Pills Price Trend, 2019-2030 (US$/Unit)

Figure 8. By Revenue, China Prescription Weight Loss Pills Share of Global Market, 2019-2030

Figure 9. By Sales Volume, China Prescription Weight Loss Pills Share of Global Market, 2019-2030

Figure 10. Global Prescription Weight Loss Pills Key Participants, Market Share, 2021 VS 2022 VS 2023

Figure 11. Global Prescription Weight Loss Pills Market Share by Company, (Tier 1, Tier 2 and Tier 3), 2022

Figure 12. China Prescription Weight Loss Pills Key Participants, Market Share, 2021 VS 2022 VS 2023

Figure 13. China Prescription Weight Loss Pills Key Participants, Market Share, 2021 VS 2022 VS 2023

Figure 14. China Prescription Weight Loss Pills Revenue, Domestic VS Import Products, Proportion of China Local Players and Foreign Players, 2019-2024

Figure 15. Chinese Local Players, Proportion of Prescription Weight Loss Pills Domestic VS Export, 2022

Figure 16. Global Prescription Weight Loss Pills Capacity, Production and Capacity Utilization, 2019-2030

Figure 17. Global Prescription Weight Loss Pills Capacity Market Share by Region, 2022 VS 2029

Figure 18. Global Prescription Weight Loss Pills Production Market Share & Forecast by Region, 2019-2030

Figure 19. Prescription Weight Loss Pills Industry Chain

Figure 20. Prescription Weight Loss Pills Procurement Model

Figure 21. Prescription Weight Loss Pills Sales Model

Figure 22. Prescription Weight Loss Pills Sales Channels, Direct Sales and Distribution

Figure 23. Oral Tablets

Figure 24. Oral Capsules

Figure 25. Injections

Figure 26. By Type, Global Prescription Weight Loss Pills Revenue, 2019-2030, US$ Million

Figure 27. By Type, Global Prescription Weight Loss Pills Revenue Market Share, 2019-2030

Figure 28. By Type, Global Prescription Weight Loss Pills Sales Volume, 2019-2030, (K Units)

Figure 29. By Type, Global Prescription Weight Loss Pills Sales Volume Market Share, 2019-2030

Figure 30. By Type, Global Prescription Weight Loss Pills Price, 2019-2030, (US$/Unit)

Figure 31. Hospital

Figure 32. Pharmacy

Figure 33. By Application, Global Prescription Weight Loss Pills Revenue, 2019-2030, US$ Million

Figure 34. By Application, Global Prescription Weight Loss Pills Revenue Market Share, 2019-2030

Figure 35. By Application, Global Prescription Weight Loss Pills Sales Volume, 2019-2030, (K Units)

Figure 36. By Application, Global Prescription Weight Loss Pills Sales Volume Market Share, 2019-2030

Figure 37. By Application, Global Prescription Weight Loss Pills Price, 2019-2030, (US$/Unit)

Figure 38. By Region, Global Prescription Weight Loss Pills Revenue Market Share, 2019-2030

Figure 39. By Region, Global Prescription Weight Loss Pills Sales Volume Market Share, 2019-2030

Figure 40. North America Prescription Weight Loss Pills Revenue & Forecasts, 2019-2030, US$ Million

Figure 41. By Country, North America Prescription Weight Loss Pills Revenue Market Share, 2022

Figure 42. Europe Prescription Weight Loss Pills Revenue & Forecasts, 2019-2030, US$ Million

Figure 43. By Country, Europe Prescription Weight Loss Pills Revenue Market Share, 2022

Figure 44. Asia Pacific Prescription Weight Loss Pills Revenue & Forecasts, 2019-2030, US$ Million

Figure 45. By Country/Region, Asia Pacific Prescription Weight Loss Pills Revenue Market Share, 2022

Figure 46. South America Prescription Weight Loss Pills Revenue & Forecasts, 2019-2030, US$ Million

Figure 47. By Country, South America Prescription Weight Loss Pills Revenue Market Share, 2022

Figure 48. Middle East & Africa Prescription Weight Loss Pills Revenue & Forecasts, 2019-2030, US$ Million

Figure 49. U.S. Prescription Weight Loss Pills Sales Volume, 2019-2030, (K Units)

Figure 50. By Company, U.S. Prescription Weight Loss Pills Market Share, 2022

Figure 51. By Type, U.S. Prescription Weight Loss Pills Sales Volume Market Share, 2022 VS 2029

Figure 52. By Application, U.S. Prescription Weight Loss Pills Sales Volume Market Share, 2022 VS 2029

Figure 53. Europe Prescription Weight Loss Pills Sales Volume, 2019-2030, (K Units)

Figure 54. By Company, Europe Prescription Weight Loss Pills Market Share, 2022

Figure 55. By Type, Europe Prescription Weight Loss Pills Sales Volume Market Share, 2022 VS 2029

Figure 56. By Application, Europe Prescription Weight Loss Pills Sales Volume Market Share, 2022 VS 2029

Figure 57. China Prescription Weight Loss Pills Sales Volume, 2019-2030, (K Units)

Figure 58. By Company, China Prescription Weight Loss Pills Market Share, 2022

Figure 59. By Type, China Prescription Weight Loss Pills Sales Volume Market Share, 2022 VS 2029

Figure 60. By Application, China Prescription Weight Loss Pills Sales Volume Market Share, 2022 VS 2029

Figure 61. Japan Prescription Weight Loss Pills Sales Volume, 2019-2030, (K Units)

Figure 62. By Company, Japan Prescription Weight Loss Pills Market Share, 2022

Figure 63. By Type, Japan Prescription Weight Loss Pills Sales Volume Market Share, 2022 VS 2029

Figure 64. By Application, Japan Prescription Weight Loss Pills Sales Volume Market Share, 2022 VS 2029

Figure 65. South Korea Prescription Weight Loss Pills Sales Volume, 2019-2030, (K Units)

Figure 66. By Company, South Korea Prescription Weight Loss Pills Market Share, 2022

Figure 67. By Type, South Korea Prescription Weight Loss Pills Sales Volume Market Share, 2022 VS 2029

Figure 68. By Application, South Korea Prescription Weight Loss Pills Sales Volume Market Share, 2022 VS 2029

Figure 69. Southeast Asia Prescription Weight Loss Pills Sales Volume, 2019-2030, (K Units)

Figure 70. By Company, Southeast Asia Prescription Weight Loss Pills Market Share, 2022

Figure 71. By Type, Southeast Asia Prescription Weight Loss Pills Sales Volume Market Share, 2022 VS 2029

Figure 72. By Application, Southeast Asia Prescription Weight Loss Pills Sales Volume Market Share, 2022 VS 2029

Figure 73. India Prescription Weight Loss Pills Sales Volume, 2019-2030, (K Units)

Figure 74. By Company, India Prescription Weight Loss Pills Market Share, 2022

Figure 75. By Type, India Prescription Weight Loss Pills Sales Volume Market Share, 2022 VS 2029

Figure 76. By Application, India Prescription Weight Loss Pills Sales Volume Market Share, 2022 VS 2029

Figure 77. Middle East & Asia Prescription Weight Loss Pills Sales Volume, 2019-2030, (K Units)

Figure 78. By Company, Middle East & Asia Prescription Weight Loss Pills Market Share, 2022

Figure 79. By Type, Middle East & Asia Prescription Weight Loss Pills Sales Volume Market Share, 2022 VS 2029

Figure 80. By Application, Middle East & Asia Prescription Weight Loss Pills Sales Volume Market Share, 2022 VS 2029

Figure 81. Research Methodology

Figure 82. Breakdown of Primary Interviews

Figure 83. Bottom-up Approaches

Figure 84. Top-down Approaches

Methodology/Research Approach

This research study involved the extensive usage of both primary and secondary data sources. The research process involved the study of various factors affecting the industry, including the government policy, market environment, competitive landscape, historical data, present trends in the market, technological innovation, upcoming technologies and the technical progress in related industry, and market risks, opportunities, market barriers and challenges. The following illustrative figure shows the market research methodology applied in this report.

Research Programs/Design

Historical Data (2015-2019)	Industry Trends Competitive Landscape By Company Expansion Mergers and Acquisitions Market Segment by Type by Application By Regions/ Geography	Value Status and Outlook Value for Major Players Market Share Growth Rate Present Situation Analysis Value Market Share Growth Rate Present Situation Analysis
Influencing Factors	Market Environment Government Policy Technological Changes Market Risks	Market Drivers Growing Demand of Downstream Reduction in Cost
Market Forecast (2021-2026)	Overall Size by Type by Application By Regions/Geography	Key Data (Value) Market Share Growth Rate CAGR (2021-2026)

Market Size Estimation

Top-down and bottom-up approaches are used to validate the global Voluntary Carbon Offset market size market and estimate the market size for Company, regions segments, product segments and Application (end users).

The market estimations in this report are based on the marketed sale price of Voluntary Carbon Offset (excluding any discounts provided by the player, distributor, wholesaler or traders). The percentage splits, market share, and breakdowns of the product segments are derived on the basis of weights assigned to each of the segments on the basis of their utilization rate and average sale price. The regional splits of the overall Voluntary Carbon Offset market and its sub-segments are based on the percentage adoption or utilization of the given product in the respective region or country.

Major Company in the market is identified through secondary research and their market revenues determined through primary and secondary research. Secondary research included the research of the annual and financial reports of the top Company; whereas, primary research included extensive interviews of key opinion leaders and industry experts such as experienced front-line staff, directors, CEOs and marketing executives. The percentage splits, market share, Growth Rate and breakdowns of the product markets are determined through using secondary sources and verified through the primary sources.

All possible factors that influence the markets included in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data. The market size for top-level markets and sub-segments is normalized, and the effect of inflation, economic downturns, and regulatory & policy changes or other factors are not accounted for in the market forecast. This data is combined and added with detailed inputs and analysis from Market Intellix and presented in this report

The following figure shows an illustrative representation of the overall market size estimation process used for this study.

Market Breakdown and Data Triangulation

After complete market engineering with calculations for market statistics; market size estimations; market forecasting; market breakdown; and data triangulation, extensive primary research was conducted to gather information and verify and validate the critical numbers arrived at. In the complete market engineering process, both top-down and bottom-up approaches were extensively used, along with several data triangulation methods, to perform market estimation and market forecasting for the overall market segments and sub-segments listed in this report. Extensive qualitative and further quantitative analysis is also done from all the numbers arrived at in the complete market engineering process to list key information throughout the report.

Data Source

Secondary Sources

Secondary sources include such as press releases, annual reports, non-profit organizations, industry associations, governmental agencies and customs data, etc. This research study involves the usage of widespread secondary sources, directories, databases such as Bloomberg Business, Wind Info, Hoovers, Factiva (Dow Jones & Company), and TRADING ECONOMICS, and News Network, statista, Federal Reserve Economic Data, annual reports, BIS Statistics, ICIS; company house documents; CAS(American Chemical Society); investor presentations; and SEC filings of companies. Secondary research was used to identify and collect information useful for the extensive, technical, market-oriented, and Hospitals study of the Voluntary Carbon Offset market. It was also used to obtain important information about the top companies, market classification and segmentation according to industry trends to the bottom-most level, and key developments related to market and technology perspectives.

Market Size	Segmental value Geographic Penetration Product Adoption Rate for Different market	Journals, Websites, and Press Releases Annual Reports and SEC Filings Company Websites and Press Releases Public and Paid Databases Market Intellix Data Repository
Market Position of Top Company	Product Financials Geographic value Mix Total Company value Business/Segmental value Mix
Qualitative Analysis	Influence Factors Market Potential Market Risks and Opportunities Industry Trends Geographical Features Government Policies	Company Websites and Press Releases Public and Paid Databases Annual Reports Industry Associations Market Intellix Data Repository

Primary Sources

In the primary research process, various sources from both the supply and demand sides were interviewed to obtain qualitative and quantitative information for this report. The primary sources from the supply side include product Company (and their competitors), opinion leaders, industry experts, research institutions, distributors, dealer and traders, as well as the raw materials suppliers and producers, etc.

The primary sources from the demand side include industry experts such as business leaders, marketing and sales directors, technology and innovation directors, supply chain executive, end use (product buyers), and related key executives from various key companies and organizations operating in the global market.

Primary research was conducted to identify segmentation Type, product price range, product Application, key Company, raw materials supply and the downstream demand, industry status and outlook, and key market dynamics such as risks, influence factors, opportunities, market barriers, industry trends, and key player strategies.

Key Executives Interviewed

Key Data Information from Primary Sources

Primary Sources	Parameters	Key Data
Market Segments(by Application, by Type)	Value by Type Status and Forecast Value by Application Value by Regions, Status and Forecast (2021-2026)	Value Market Share by Type Value Growth Rate by Type Value by Application Percentage and Growth Rate by Application Value Growth Rate and Market Share by Regions Market Size Status and Forecast (2021-2026)
Total Market	Overall Size, Status and Forecast	Market Size Status and Forecast (2021-2026)